Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) has a cash flow conversion efficiency ratio of -0.212x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-19.96 Million ≈ $-2.92 Million USD) by net assets (CN¥94.30 Million ≈ $13.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 600671 stock market capitalisation for the company's overall valuation and market capitalisation.
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd ranked by their cash flow conversion efficiency. Explore 600671 operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Memsensing Microsystems Suzhou China Co Ltd
SHG:688286
|
0.095x |
|
Fidere Patrimonio SOCIMI SA
MC:YFID
|
0.320x |
|
Coca-Cola Europacific Partners PLC
LSE:CCEP
|
0.105x |
|
Misun Technology Co Ltd
SHE:301577
|
N/A |
|
Shanghai Laimu Electronics Co Ltd
SHG:603633
|
-0.006x |
|
Tellgen Corp
SHE:300642
|
0.025x |
|
China Sanjiang Fine Chemicals Company Limited
F:8C9
|
0.032x |
|
Servcorp Ltd
AU:SRV
|
0.361x |
Annual Cash Flow Conversion Efficiency for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd from 1998 to 2025. View Hangzhou TianMuShan Pharmaceutical Enter stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥93.99 Million ≈ $13.75 Million |
CN¥11.79 Million ≈ $1.73 Million |
0.125x | +129.08% |
| 2024-12-31 | CN¥85.02 Million ≈ $12.44 Million |
CN¥-36.67 Million ≈ $-5.37 Million |
-0.431x | -18.14% |
| 2023-12-31 | CN¥55.95 Million ≈ $8.19 Million |
CN¥-20.43 Million ≈ $-2.99 Million |
-0.365x | +91.56% |
| 2022-12-31 | CN¥4.48 Million ≈ $655.53K |
CN¥-19.37 Million ≈ $-2.83 Million |
-4.324x | -956.52% |
| 2021-12-31 | CN¥64.56 Million ≈ $9.45 Million |
CN¥-26.42 Million ≈ $-3.87 Million |
-0.409x | -354.96% |
| 2020-12-31 | CN¥93.33 Million ≈ $13.66 Million |
CN¥-8.40 Million ≈ $-1.23 Million |
-0.090x | -107.44% |
| 2019-12-31 | CN¥133.33 Million ≈ $19.51 Million |
CN¥161.13 Million ≈ $23.58 Million |
1.209x | +39.51% |
| 2018-12-31 | CN¥81.62 Million ≈ $11.94 Million |
CN¥70.71 Million ≈ $10.35 Million |
0.866x | +240.09% |
| 2017-12-31 | CN¥96.27 Million ≈ $14.09 Million |
CN¥24.52 Million ≈ $3.59 Million |
0.255x | +949.12% |
| 2016-12-31 | CN¥66.18 Million ≈ $9.68 Million |
CN¥1.61 Million ≈ $235.13K |
0.024x | +203.93% |
| 2015-12-31 | CN¥62.76 Million ≈ $9.18 Million |
CN¥-1.47 Million ≈ $-214.52K |
-0.023x | -404.59% |
| 2014-12-31 | CN¥85.25 Million ≈ $12.47 Million |
CN¥653.79K ≈ $95.67K |
0.008x | -94.10% |
| 2013-12-31 | CN¥95.26 Million ≈ $13.94 Million |
CN¥12.37 Million ≈ $1.81 Million |
0.130x | +160.78% |
| 2012-12-31 | CN¥92.76 Million ≈ $13.57 Million |
CN¥-19.82 Million ≈ $-2.90 Million |
-0.214x | -501.81% |
| 2011-12-31 | CN¥182.84 Million ≈ $26.75 Million |
CN¥-6.49 Million ≈ $-950.05K |
-0.036x | +56.56% |
| 2010-12-31 | CN¥154.14 Million ≈ $22.55 Million |
CN¥-12.60 Million ≈ $-1.84 Million |
-0.082x | -302.37% |
| 2009-12-31 | CN¥187.74 Million ≈ $27.47 Million |
CN¥7.58 Million ≈ $1.11 Million |
0.040x | -54.19% |
| 2008-12-31 | CN¥240.30 Million ≈ $35.16 Million |
CN¥21.19 Million ≈ $3.10 Million |
0.088x | -47.51% |
| 2007-12-31 | CN¥282.93 Million ≈ $41.40 Million |
CN¥47.53 Million ≈ $6.96 Million |
0.168x | -28.28% |
| 2006-12-31 | CN¥236.44 Million ≈ $34.60 Million |
CN¥55.39 Million ≈ $8.10 Million |
0.234x | +561.08% |
| 2005-12-31 | CN¥239.39 Million ≈ $35.03 Million |
CN¥8.48 Million ≈ $1.24 Million |
0.035x | +560.32% |
| 2004-12-31 | CN¥252.36 Million ≈ $36.93 Million |
CN¥1.35 Million ≈ $198.17K |
0.005x | +103.17% |
| 2003-12-31 | CN¥242.64 Million ≈ $35.51 Million |
CN¥-41.13 Million ≈ $-6.02 Million |
-0.170x | -296.91% |
| 2002-12-31 | CN¥253.20 Million ≈ $37.05 Million |
CN¥21.80 Million ≈ $3.19 Million |
0.086x | +105.99% |
| 2001-12-31 | CN¥251.63 Million ≈ $36.82 Million |
CN¥10.52 Million ≈ $1.54 Million |
0.042x | +208.63% |
| 2000-12-31 | CN¥251.29 Million ≈ $36.77 Million |
CN¥-9.67 Million ≈ $-1.41 Million |
-0.038x | -119.13% |
| 1999-12-31 | CN¥244.10 Million ≈ $35.72 Million |
CN¥49.09 Million ≈ $7.18 Million |
0.201x | +1911.55% |
| 1998-12-31 | CN¥235.71 Million ≈ $34.49 Million |
CN¥2.36 Million ≈ $344.84K |
0.010x | -- |
About Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, together with its subsidiaries, engages in the pharmaceutical manufacturing and drug distribution businesses in China. The company produces tablets, granules, pills, oral solutions, and other medications; and health food products, including oral liquids, syrups, eye drops, pills, soft capsules, tablets, and granules. It also sells prepared sl… Read more